Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 7 of 7 citing Bril: Sural nerve sorbitol in patients with diabetic sensorimotor polyneuropathy. (0.08 sec) 

Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic …


V Bril, RA Buchanan - Diabetes Care, 2004 - Am Diabetes Assoc
OBJECTIVE—The primary purpose of this investigation was to determine whether AS-3201,
a new aldose reductase inhibitor, penetrates the sural nerve and inhibits sorbitol and fructose
accumulation in patients with diabetic sensorimotor polyneuropathy (DSP). An additional ...
Cited by 49 - Related articles - BL Direct - All 7 versions

Long-term effects of ranirestat (AS-3201) on peripheral nerve function in patients …


V Bril, RA Buchanan - Diabetes Care, 2006 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—Patients with mild to moderate DSP, as determined
by the presence of sural nerve responses, were enrolled in a double-blind, placebo-controlled
biopsy trial and randomized to placebo or 5 or 20 mg/day ranirestat for 12 weeks. Patients ...
Cited by 45 - Related articles - BL Direct - All 6 versions

Emerging therapies for diabetic neuropathy: a clinical overview


BA Perkins, V Bril - Current Diabetes Reviews, 2005 - ingentaconnect.com
Abstract: This paper reviews emerging interventions from the recent clinical literature that demonstrate
the potential for effectiveness in the therapy of the diverse forms of diabetic neuropathy. Diabetic
sensorimotor polyneuropathy is the primary focus of this review given that it is the most ...
Cited by 3 - Related articles - BL Direct - All 2 versions

Sequelae following sural nerve biopsy in type 1 diabetic subjects


LB Dahlin, F Lithner, LE Bresater, NOB … - Acta Neurologica …, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Related articles - All 3 versions

Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications


N Giannoukakis - Expert Opin. Investig. Drugs, 2008 - informahealthcare.com
Background: There are currently very few drugs available to directly treat diabetic
complications. Those that are indicated clinically provide symptomatic relief and do not address
the underlying biochemical problems. The involvement of the sorbitol pathway in ...
Related articles - BL Direct - All 7 versions

HPLC with pulsed amperometric detection for sorbitol as a biomarker for diabetic …


HJ Sim, JS Jeong, HJ Kwon, TH Kang, HM Park, … - … of Chromatography B, 2009 - Elsevier
This study describes the optimal analytical conditions for sorbitol analysis by a high-performance
anion-exchange chromatography-pulsed amperometric detection method. Its clinical utility as
a diagnostic tool was established by measuring sorbitol in the sciatic nerves or salivary ...
Related articles - All 2 versions

[PDF] FILLING THE GAP: EMERGING TREATMENTS FOR DIABETIC NEUROPATHY


B Vera Bril - jhasim.com
Neuropathy is a common diabetic microvascu- lar complication, which can be associated with
sig- nificant positive symptoms for the patient, such as numbness, prickling, aching pain, burning
pain, lancinating pain, or allodynia, and in advanced cases, may eventually lead to ...
Related articles - All 3 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google